NCT04660760
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04660760
Title Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233 United States Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
Cleveland Clinic-Weston Weston Florida 33331 United States Details
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242 United States Details
Metro Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
Saint Vincent Hospital Cancer Center Green Bay Green Bay Wisconsin 54301 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field